CFDE Data Portal | Search MIR2117HG

	Label	Description
	MIR2117HG Gene (Entity type)	ENSG00000267151 - MIR2117 host gene
	GSE115542 digoxin 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 11 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE101754 FXR1 knockdown NCI-H358 1 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680 GSE182683 dexamethasone 0 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE207499 sphingosine 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE235701 GSE261434 enasidenib 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE229973 cisplatin 3 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE184892 trehalose fibroblast 6 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE193541 nifurtimox A-549 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS

MIR2117HG

ENSG00000267151 - MIR2117 host gene

GSE115542 digoxin 2 v 0 human up

A Gene Set from LINCS

GSE111247 temozolomide LN-308 11 v 3 human dn

A Gene Set from LINCS

GSE101754 FXR1 knockdown NCI-H358 1 v 4 human up

A Gene Set from LINCS

GSE182680 GSE182683 dexamethasone 0 v 11 human dn

A Gene Set from LINCS

GSE207499 sphingosine 1 v 0 human dn

A Gene Set from LINCS

GSE235701 GSE261434 enasidenib 2 v 1 human up

A Gene Set from LINCS

GSE229973 cisplatin 3 v 6 human dn

A Gene Set from LINCS

GSE184892 trehalose fibroblast 6 v 5 human dn

A Gene Set from LINCS

GSE193541 nifurtimox A-549 0 v 3 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.